Assessing the Utility of ColabFold and AlphaMissense in Determining Missense Variant Pathogenicity for Congenital Myasthenic Syndromes.
Ryan-Phillips F. et al, (2024), Biomedicines, 12
Congenital myasthenic syndromes: increasingly complex.
Ramdas S. et al, (2024), Curr Opin Neurol, 37, 493 - 501
Unraveling the molecular interactions between α7 nicotinic receptor and a RIC3 variant associated with backward speech.
Pradhan A. et al, (2024), Cell Mol Life Sci, 81
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Pagnamenta AT. et al, (2023), Genome Med, 15
260th ENMC International Workshop: Congenital myasthenic syndromes 11-13 March 2022, Hoofddorp, The Netherlands.
Spendiff S. et al, (2023), Neuromuscul Disord, 33, 111 - 118
A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
Rodríguez Cruz PM. et al, (2023), Neuromuscul Disord, 33, 161 - 168
Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre.
Poulos J. et al, (2023), Brain Commun, 5
Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients.
Nagaoka A. et al, (2022), J Neurol Sci, 443
Pregnancy outcomes in patients with congenital myasthenic syndromes.
O'Connell K. et al, (2022), Muscle Nerve, 66, 345 - 348
Rituximab in juvenile myasthenia gravis-an international cohort study and literature review.
Ramdas S. et al, (2022), Eur J Paediatr Neurol, 40, 5 - 10
Genetic defects are common in myopathies with tubular aggregates.
Gang Q. et al, (2022), Ann Clin Transl Neurol, 9, 4 - 15
Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report.
Ehrstedt C. et al, (2022), Neuromuscul Disord, 32, 80 - 83
Antagonistic postsynaptic and presynaptic actions of cyclohexanol on neuromuscular synaptic transmission and function.
Dissanayake KN. et al, (2021), J Physiol, 599, 5417 - 5449
Presynaptic congenital myasthenic syndrome due to three novel mutations in SLC5A7 encoding the sodium-dependant high-affinity choline transporter.
Rodríguez Cruz PM. et al, (2020), Neuromuscul Disord
Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure.
Rodríguez Cruz PM. et al, (2020), Hum Mutat, 41, 619 - 631
β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Vanhaesebrouck AE. et al, (2019), Brain
Muscle acetylcholine receptor conversion into chloride conductance at positive potentials by a single mutation.
Cetin H. et al, (2019), Proc Natl Acad Sci U S A, 116, 21228 - 21235
The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies.
Vanhaesebrouck AE. and Beeson D., (2019), Curr Opin Neurol, 32, 696 - 703
Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.
Balaraju S. et al, (2019), Eur J Hum Genet